NKR-P1+ cells localize selectively in rat 9L gliosarcomas but have reduced cytolytic function

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3516-3525

  Chambers, William H ^a   Bozik, Michael E ^b   Brissette Storkus, Cynthia S ^a   Basse, Per ^a   Redgate, Ed ^b   Watkins, Simon ^b   Boggs, Sallie S ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; GLIOSARCOMA; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL;

ANIMALS; ANTIGENS, SURFACE; BRAIN NEOPLASMS; GLIOSARCOMA; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; RATS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0029681682     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Davis, L. W. Malignant glioma: nemesis which requires clinical and basic investigation in radiation oncology Int. J. Radiat. Oncol. Biol. Phys., 16: 1355-1365, 1989.
2. Greig, N. H., Ries, L. G., Yancik, R., and Rapoport, S. I. Increasing annual incidence of primary malignant brain tumors in the elderly. J. Natl. Cancer Inst., 82: 1621-1624, 1990.
3. Walker, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., and Maholey, M. S. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J. Neurosurg., 49: 333-343, 1978.
4. Walker, M. D., Green, S. B., Byar, D. P., Alexander, E., and Bratzdorf, U. Randomized comparisons of radiotherapy and nitrosourea for the treatment of malignant glioma after surgery. N. Engl. J. Med., 303: 1323-1329, 1980.
5. 125I] iodo-2′-deoxyuridine in rat brain tumors. Cancer Res., 50: 5199-5203, 1990.
6. Gutin, P. H., Leibel, S. A., Wara, W. M., Choucair, A., Levin, V. A., Phillips, T. L., Silver, P., Da Silva, V., Edwards, M. S. B., Davis, R. L. Weaver, D. A., and Lamb, S. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources J. Neurosurg., 67: 864-873, 1987.
7. Gutin, P. H., Phillips, T. L., Hosobuchi, Y., Wara, W. M., Mackay, A. R., Weaver, K. A., Lamb, S., and Hurst, S. Permanent and removable implants for brachytherapy of brain tumors. Int. J. Radiat. Oncol. Biol. Phys., 7: 1371-1381, 1981.
8. Gutin, P. H., Phillips, T. L., Wara, W. M., Leibel, S. A., Hosobuchi, Y., Levin, V. A., Weaver, K. A., and Lamb, S. Brachytherapy of recurrent malignant brain tumors with removable high activity iodine-125 sources. J. Neurosurg., 60: 61-68, 1984.
9. Munninger, F., and Weigel, K. Long term results of stereotactic interstitial curietherapy. Acta Neurol., 33: 367-371, 1984.
10. Szilka, G., Schienger, M., Blond, S., Daumas-Duport, C., Missir, O., Miyshara, S., Musolino, A., and Shaub, C. Interstitial and combined irradiation of supratentorial gliomas: results of 61 cases treated 1973-1981. Acta Neurochir., 33: 355-362, 1984.
11. Loeffler, J. S., Alexander, E., Hochberg, F. H., Wen, P. Y., Morris, J. H., Schoene, W. C., Siddon, R. L., Morse, R. H., and Black, P. M. 1990 Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys., 19: 1455-1462, 1990.
12. Jellinger, K. Pathology of human intracranial neoplasia. In: K. Jellinger (ed.), Therapy of Malignant Brain Tumors, pp. 1-67. Berlin: Springer-Verlag, 1987.
13. Boker, D. K. Lymphocytic infiltration of intracranial tumors. Morphologic evidence for a host-immune reaction and comparison with the leukocyte migration test. Clin. Neuropathol., 1: 113-120, 1982.
14. Boker, D. K., and Gullotta, F. Mononuclear infiltrates in human brain tumors, possible morphological equivalence of an immunological defense reaction. In: D. Voth and P. Krauseneck (eds.), Chemotherapy of Gliomas, pp. 87-92. Berlin: De Guyter, 1985
15. Boker, D. K., Kalff, R., Gullotta, F., Weekes-Siefert, S., and Mohrer, S. Mononuclear infiltrates in human intracranial tumors as a prognostic factor Influence of preoperative steroid treatment. I. Glioblastoma. Clin. Neuropathol., 3: 143-147, 1984.
16. Jellinger, K. Glioblastoma multiforme. Acta Neurochir., 42: 5-32, 1987.
17. Von Hanwehr, R. L., Hofman, F. M., Taylor, C. R., and Apuzzo, M. L. J. Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors J. Neurosurg., 60: 1138-1147, 1984.
18. Bagshawe, K. D. Risk and prognostic factors in trophoblastic neoplasia. Cancer (Phila.), 58: 1375-1378, 1976.
19. Bloom, H. J. G., Richardson, W. W., and Field, J. G. Host resistance and survival in carcinoma of the breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br. Med. J., 3: 181-188, 1970.
20. Boekstegers, A., and Grundmann, E. What's new in natural killer cells? Pathol. Res. Pract., 180: 536-552, 1985.
21. Underwood, J. C. E. Lymphoreticular infiltration in human tumors: prognostic and biological implications. Br. J. Cancer, 30: 538-548, 1974.
22. Mork, S. J., Nyland, H., Matre, R., and Ganz, J. Characterization of host mononuclear cells in gliomas. J. Neuropathol. Exp. Neurol., 44: 317, 1985.
23. Neuwelt, E. Y., and Smith, R. G. Presence of lymphocyte surface markers on "small cells" in pineal germinoma. Ann. Neurol., 6: 133-136, 1979.
24. Stavrou, D., Anzil, A. P., Weidenbach, W., and Roul, H. Immunofluorescence study of lymphocytic infiltration in gliomas. J. Neurol. Sci., 33: 275-282, 1977.
25. Wood, G., and Morantz, R. A. Immunohistologic evaluation of the lymphoreticular infiltrate in human central nervous system tumors. J. Natl. Cancer Inst., 62: 485-491, 1979.
26. Weller, R. O. The immunopathology of brain tumours. In. N. M. Bleechan (ed.), Tumours of the Brain, pp. 19-33, Berlin: Springer-Verlag, 1986.
27. McGarry, R. C., Pinto, A., Hammersley-Straw, D. R. H., and Trevenen, C. L. Expression of human markers shared between human natural killer cells and neuroblastoma lines. Cancer Immunol. Immunother., 27: 47-52, 1988.
28. Lanier, L. L., Testi, R., Bindl, J., and Phillips, J. H. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med., 169: 2233-2228, 1989.
29. Farmer, J. P., Antel, J. P., Freedman, M., Cahsman, N. R., Rode, H., and Villemure, J. G. Characterization of the lymphoid cells isolated from human gliomas. J. Neurosurg., 71: 528-533, 1989.
30. Merchant, R. E., Ellison, M. D., and Young, H. F. Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. J. Neuro-oncol., 70: 173-180, 1990.
31. Schmidek, H. H., Nielson, S. L., Shillel, A. L., and Messer, J. Morphological studies of rat brain tumors induced by N-nitromethylurea. J. Neurosurg., 34: 335-340, 1971.
32. Wen, P., Loeffler, J. S., Morris, J. H., and Lampson, L. A. The effects of irradiation on major histocompatibility expression and lymphocytic infiltration in the normal rat brain and the 9L gliosarcoma brain tumor model. J. Neuroimmunol., 27: 239-244, 1990.
33. Wen, P. Y., Lampson, M. A., and Lampson, L. A. Effects of γ-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies for immunotherapy. J. Neuroimmunol., 36: 57-68, 1992.
34. Lampson, L. A., Wen, P., Roman, V. A., Morris, J. H., and Sand, J. A. Disseminating tumor cells and their interactions with leukocytes visualized in the brain. Cancer Res., 52: 1018-1025, 1992.
35. Tzeng, J-J., Barth, R. E., Orosz, C. G., and James, S. M. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Cancer Res., 51: 2373-2378, 1991.
36. Holladay, F. P., Lopez, G., De, M., Morantz, R. A., and Wood, G. W. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells. Neurosurgury (Baltimore), 30: 499-504, 1992.
37. Chambers, W. H., Vujanovic, N. L., DeLeo, A. B., Olszowy, M. W., Herberman, R. B., and Hiserodt, J. C. Monoclonal antibody to a triggering structure expressed on rat NK and A-LAK cells J. Exp. Med., 169: 1373-1381, 1989.
38. Vujanovic, N. L., Herberman, R. B., Olszowy, M. W., Cramer, D. V., Salup, R. R., Reynolds, C. W., and Hiserodt, J. C. Lymphokine activated killer cells in rats, analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Cancer Res., 48: 884-890, 1988.
39. Baume, D. M., Caligiuri, M. A., Manley, T. J., Daley, J. F., and Ritz, J. Differential expression of CD8 α and β associated with MHC-restricted and non-MHC restricted cytolytic effector cells. J. Exp. Med., 131: 352-365, 1990.
40. - subset of rat T cells. J. Immunol., 152: 388-396, 1994.
41. dim subpopulations of rat natural killer cells. J. Immunol., 148: 3658-3665, 1992.
42. Kaufman, C. L., Chambers, W. H., and Ildstad, S. T. Co-expression of NKR-P1 and TCRαβ on lymphoid cells in fully xenogeneic (rat → mouse) chimeras and syngeneically reconstituted (A → A) rats. J. Immunol., 151: 6002-6011, 1993.
43. Lanier, L. L., Chang, C., and Phillips, J. H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by NK and T lymphocytes. J. Immunol., 153: 2417-2428, 1994.
44. Trinchieri, G. Immunobiology of natural killer cells. Adv. Immunol., 147: 187-336, 1989.
45. de Micco, C. Immunology of central nervous system tumors. J. Neuroimmunol., 25: 93-108, 1989.
46. Imaya, H., Matsuura, H., Kendo, M., and Nakazawa, S. Suppression of splenic natural killer cell activity in rats with brain tumors. Neurosurgery (Baltimore), 23: 23-32, 1988.
47. Matsuura, M., and Imaya, H. Comparison of lymphokine-activated killer activities between thymocytes and splenocytes in rats with brain tumors. Cancer Immunol. Immunother., 33: 50-53, 1991.
48. Imboden, J. C., Erriksson, E. C., McCutcheon, M., Reynolds, C. W., and Seaman, W. E. Identification and characterization of a cell-surface molecule that is selectively induced on rat lymphokine activated killer cells. J. Immunol., 143: 3100-3107, 1989.
49. + natural killer cells in tissues from normal and tumor-bearing rats Cancer Res., 51: 4931-4936, 1991.
50. - cell lines. Nat. Immun., 14: 98-113, 1995.
51. Ryan, J. C., Neimi, E. C., Goldfein, R. D., Hiserodt, J. C., and Seaman, W. E. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J. Immunol., 149: 1631-1640, 1991.
52. Webster, G. A., Bowles, M. J., Karim, M. S., Wood, R. F. M., and Pockley, A. G. Activation antigen expression on peripheral blood neutrophils following rat small bowel transplantation: NKR-P1 is a novel antigen preferentially expressed during allograft rejection. Transplantation (Baltimore), 58: 707-713, 1994.
53. Maghazachi, A. A., Vujanovic, N. L., Herberman, R. B., and Hiserodt, J. C., Lymphokine-activated killer cells in rats. IV Developmental relationships among large agranular lymphocytes, large granular lymphocytes and lymphokine-activated killer cells. J. Immunol., 140: 2846-2852, 1988.
54. Bodmer, S., Strommer, K., Frei, K., Siepl, C., de Tribolet, N., Heid I., and Fontana, A. Immunosuppression and TGFβ in glioblastoma. J. Immunol., 143: 3222-3229, 1989.
55. Bodmer, S., Siepl, C., and Fontana, A. Immunoregulatory factors secreted by glioblastoma cells In: E. J. Goetzl (ed.), Neuroimmune Networks: Physiology and Diseases, pp. 73-82. New York: Alan R. Liss, Inc., 1989.
56. Fontana, A., Bodmer, S., Frei, K., Malipiero, U., and Siepl, C. Expression of TGFβ2 in human glioblastoma: a role in resistance to immune rejection. CIBA Found. Symp., 157: 232-238, 1991.
57. - cells produce IL4. J. Immunol., 149: 1121-1115, 1992.
58. + thymocytes with specific lymphokine secretion. Eur. J. Immunol., 23: 307-310, 1993.
59. pos T cells promptly produce IL4 in response to in vivo challenge with anti-CD3. J. Exp. Med., 179: 1285-1295, 1994.
60. + cells. New clues to their origin, specificity and function. J. Exp. Med., 182: 633-638, 1995.
61. Bozik, M. E., Chambers, W. H., Lotze, M. T., Fellows, W., Suhajda, K., Harding, B., and Gilbert, M. R. T-cell dependent intracerebral tumor regression of a 9L gliosarcoma expressing mIL4 in a syngeneic host Proc. Am. Assoc. Cancer Res., 36: 470, 1996.